GenSci Seeking To Stay Injunction Of DynaGraft Gel, Putty Products
This article was originally published in The Gray Sheet
Executive Summary
GenSci is planning to appeal a Los Angeles jury's $14.5 mil. damage award to Osteotech for patent infringement through the sale of its DynaGraft Gel and Putty bone products
You may also be interested in...
Osteotech’s Discontinued bio-d Bone Dowel Constituted About 3% Of Sales
Osteotech will cease production of its bio-d threaded cortical bone dowel system by Jan. 31, 2003 under a patent infringement settlement with Medtronic's Sofamor Danek unit, announced April 30
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.